Why Vertex Pharmaceuticals Incorporated (VRTX) is the Best Pharma Stock to Buy According to Hedge Funds
We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Where Will Vertex Pharmaceuticals Be in 10 Years?
Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic ...
Should You Consider Adding Vertex Pharmaceuticals Incorporated (VRTX) to Your Portfolio?
In its fourth quarter 2024 investor letter, Parnassus Core Equity Fund emphasized stocks such as Vertex Pharmaceuticals ...
MoneyWeek on MSN8d
Vertex Pharmaceuticals is an uncommon opportunity in rare diseases
Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success, says Dr Michael Tubbs ...
Vertex, Inc. to Host 2025 Investor Day
KING OF PRUSSIA, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) today announced that it will host an Investor Day on Wednesday, March 19, in Philadelphia, PA. The event will ...
Vertex Pharmaceuticals: Company Passes My Health Check With Flying Colors, Upholding Buy Rating
Vertex Pharmaceuticals demonstrates resilience with robust CF franchise, new approvals, and diversification efforts. Read why ...
Vertex’s non-opioid pain drug gets some UnitedHealth coverage
The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...
Fierce Pharma8d
Vertex puts patient’s story at heart of National Kidney Month awareness drive
Rouse had presented with symptoms including intense swelling in her legs that she originally thought could be linked to her ...
Exploring 3 High Growth Tech Stocks In The US Market
Over the last 7 days, the United States market has dropped 2.7%, but it has shown resilience with an 11% rise over the past year and earnings forecasted to grow by 14% annually. In this context, ...
3 Reasons to Avoid VRTX and 1 Stock to Buy Instead
Is now the time to buy Vertex Pharmaceuticals, or should you be careful about including it in your portfolio? Check out our in-depth research report to see what our analysts have to say, it’s free. We ...
Bloomberg L.P.8d
Vertex’s Non-Opioid Pain Drug Gets Some UnitedHealth Coverage
Vertex Pharmaceuticals Inc.’s new non-opioid ... The medication, called Journavx, got US regulatory clearance in January. The financial success of new drugs largely depends on how they’re ...